ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Tepmetko 225 mg, Filmtabletten - 60
68113001 Merck (Schweiz) AG
Tepmetko 225 mg, Filmtabletten22.06.2021
  22.06.2021
Tepotinib (L01EX21) 
WHO-DDD14.12.2028
07.16.10.60
07.16. 
A  
Yes 
IPCI
5981.89Yes
    
10 %6445.20
  
7680681130017Synthetika
  
Composition
tepotinibum 225 mg ut tepotinibi hydrochloridum monohydricum 250 mg, mannitolum 455.33 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, lactosum monohydricum 4.37 mg, macrogola, triacetinum, E 171, E 172 (rubrum), pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Tepotinibum225 mg
BAG: Active AgentDose
Tepotinibum225 mg
 
Inactive agentsDoseadditional_information
(Rubrum)  
Cellulosum Microcristallinum  
Crospovidonum  
E 171 color.
E 172 color.
Hypromellosum Überzug
Lactose Monohydrate4.37 mg 
Macrogola  
Magnesii Stearas  
Mannitol455.33 mg 
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Triacetinum  
 
Source
Data was imported : 05.01.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home